Ethanol septal reduction for symptomatic hypertrophic cardiomyopathy

被引：0
|
作者：
Lakkis, NM [1 ]
Kleiman, NS [1 ]
Killip, DM [1 ]
Spencer, WH [1 ]
机构：
[1] BAYLOR COLL MED,HOUSTON,TX 77030
来源：
CIRCULATION | 1997年 / 96卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1203 / 1203
页数：1
相关论文
共 50 条
  • [41] LONG-TERM OUTCOME OF PERCUTANEOUS SEPTAL ABLATION FOR SYMPTOMATIC HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
    Faber, Lothar
    Prinz, Christian
    Schumann, Martina
    Burghardt, Amelie
    Seggewiss, Hubert
    Horstkotte, Dieter
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E1228 - E1228
  • [42] Successful Surgical Management of Severely Symptomatic Hypertrophic Cardiomyopathy Patients With Minimal Septal Hypertrophy
    Ahmad, Raabia N.
    Maron, Barry J.
    Rowin, Ethan J.
    Haas, Tammy S.
    Dearani, Joseph A.
    Maron, Martin S.
    CIRCULATION, 2014, 130
  • [43] Left Ventricular Systolic Function Following Alcohol Septal Ablation for Symptomatic Hypertrophic Cardiomyopathy
    Moss, Travis J.
    Krantz, Mori J.
    Zipse, Matthew M.
    Quaife, Robert A.
    Sauer, William H.
    Messenger, John C.
    Groves, Bertron M.
    Salcedo, Ernesto E.
    Schuller, Joseph L.
    AMERICAN JOURNAL OF CARDIOLOGY, 2014, 113 (08): : 1401 - 1404
  • [44] Long-term outcome of percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy
    Faber, L.
    Welge, D.
    Seggewiss, H.
    Hering, D.
    Oldenburg, O.
    Horstkotte, D.
    EUROPEAN HEART JOURNAL, 2009, 30 : 183 - 183
  • [45] Time course of gradient reduction during septal ethanol ablation for obstructive hypertrophic cardiomyopathy is related to changes in myocardial mechanics
    Carasso, Shemy
    Woo, Anna
    Yang, Hue
    Schwartz, Leonard
    Jamorski, Michel
    Vannan, Man A.
    Rakowski, Harry
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 57A - 57A
  • [46] Long-term outcome of percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy
    Faber, L.
    Prinz, C.
    Burghardt, A.
    Seggewiss, H.
    Horstkotte, D.
    EUROPEAN HEART JOURNAL, 2014, 35 : 925 - 925
  • [47] How Symptomatic Should a Hypertrophic Obstructive Cardiomyopathy Patient Be to Consider Alcohol Septal Ablation?
    Jones, Brandon M.
    Krishnaswamy, Amar
    Smedira, Nicholas G.
    Desai, Milind Y.
    Tuzcu, E. Murat
    Kapadia, Samir R.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (05):
  • [48] LONG-TERM OUTCOME OF PERCUTANEOUS SEPTAL ABLATION FOR SYMPTOMATIC HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
    Faber, Lothar
    Welge, Dirk
    Seggewiss, Hubert
    Hering, Detlef
    Oldenburg, Olaf
    Horstkotte, Dieter
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [49] Therapeutic effects of alcohol septal ablation in mildly symptomatic patients with hypertrophic obstructive cardiomyopathy
    李佩瑾
    ChinaMedicalAbstracts(InternalMedicine), 2022, 39 (02) : 95 - 96
  • [50] CAN ALCOHOL SEPTAL ABLATION REPLACE SURGICAL MYECTOMY IN SYMPTOMATIC HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY?
    Pati, P.
    Chandy, S.
    George, P.
    Jose, J.
    Joseph, G.
    INTERNAL MEDICINE JOURNAL, 2011, 41 : 25 - 25
12345